Related Experiment Video
Updated: Jul 4, 2026
10:31
Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
Testis specific lactate dehydrogenase as target for immunoliposomes.
Ranjna C Dutta1, Erwin Goldberg
1Department of Biochemistry, Molecular Biology and Cell Biology Northwestern University, Evanston, IL 60208, USA. ranjna_dutta@rediffmail.com
Summary
Targeting the testis for drug delivery is possible using immunoliposomes. These specifically target lactate dehydrogenase-C4 (LDH-C(4)) on sperm and testes, enabling agent delivery.
Area of Science:
- Reproductive biology
- Nanomedicine
- Drug delivery systems
Background:
- The testis presents a unique challenge for targeted therapeutic agent delivery.
- Developing specific delivery mechanisms is crucial for reproductive health interventions.
Purpose of the Study:
- To investigate the feasibility of targeted therapeutic agent delivery to the testis.
- To evaluate immunoliposomes engineered for testis-specific targeting.
Main Methods:
- Immunoliposomes were created by incorporating antibodies against lactate dehydrogenase-C4 (LDH-C(4)).
- LDH-C(4) is a protein specifically expressed in the testis.
- Targeting and delivery capabilities were assessed in vitro and in vivo.
Main Results:
- LDH-C(4)-immunoliposomes demonstrated specific recognition of antigens on spermatozoa and testicular tissues.
- Effective targeting was observed in both in vitro and in vivo experimental models.
Conclusions:
- Targeting lactate dehydrogenase-C4 (LDH-C(4)) is a viable strategy for delivering agents to the testis.
- This approach holds potential for both therapeutic and anti-spermatogenic applications.
